Subramanyam Rajeev, Varughese Anna, Kurth Charles Dean, Eckman Mark H
Department of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Paediatr Anaesth. 2014 May;24(5):467-75. doi: 10.1111/pan.12359. Epub 2014 Mar 5.
The primary outcome of this study was to examine the cost-effectiveness of the intraoperative combination of intravenous (IV) acetaminophen and IV opioids, versus IV opioids alone, as a part of an inhalational anesthetic technique for tonsillectomy in children.
We used Decision Maker® software to construct and analyze a decision analytic model. Base-case and sensitivity analyses were performed. We studied the use of rescue analgesics in the postanesthesia care unit (PACU), adverse effects of acetaminophen and opioids, and costs associated with adverse effects. Costs were in 2013 US dollars, and effectiveness was measured as frequency of avoiding the need for rescue analgesics. Direct medical costs included medication, equipment, supplies, and labor associated with the treatment of adverse events from pain medications. Medication costs assumed single-dose vials.
In the base case, IV acetaminophen in combination with opioids was both less costly ($17.12) and more effective (3.3% fewer rescue events). In sensitivity analyses, the combination strategy remained cost-effective as long as the frequency of rescue analgesic administration was less than that in the opioid-alone strategy. Although medication costs of the combination strategy were higher, the overall costs were less than the competing strategy due to reduced adverse effects and reduced time spent in PACU.
The routine use of IV acetaminophen as an adjuvant to IV opioids for tonsillectomy with or without adenoidectomy in children aged <17 years should be considered as a means to reduce the need for rescue analgesia and in turn reduce costs.
本研究的主要结果是,作为儿童扁桃体切除术吸入麻醉技术的一部分,研究静脉注射(IV)对乙酰氨基酚与静脉注射阿片类药物联合使用,相对于单独使用静脉注射阿片类药物的成本效益。
我们使用Decision Maker®软件构建并分析了一个决策分析模型。进行了基础病例分析和敏感性分析。我们研究了在麻醉后护理单元(PACU)中使用急救镇痛药的情况、对乙酰氨基酚和阿片类药物的不良反应以及与不良反应相关的成本。成本以2013年美元计算,有效性以避免使用急救镇痛药的频率来衡量。直接医疗成本包括与疼痛药物不良事件治疗相关的药物、设备、用品和劳动力成本。药物成本假设为单剂量小瓶。
在基础病例中,静脉注射对乙酰氨基酚与阿片类药物联合使用的成本更低(17.12美元)且更有效(急救事件减少3.3%)。在敏感性分析中,只要急救镇痛药的给药频率低于单独使用阿片类药物的策略,联合策略就仍然具有成本效益。虽然联合策略的药物成本较高,但由于不良反应减少和在PACU花费的时间减少,总体成本低于竞争策略。
对于17岁以下儿童进行扁桃体切除术(无论是否同时进行腺样体切除术),应考虑常规使用静脉注射对乙酰氨基酚作为静脉注射阿片类药物的辅助药物,以减少急救镇痛的需求,进而降低成本。